Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (JNJ)
NYSE:JNJ
JNJ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$140.68 - $169.99
Previous CloseN/A
Volume3.80M
Average Volume (3M)9.28M
Market Cap
$399.65B
Enterprise Value$365.36B
Total Cash (Recent Filing)$14.34B
Total Debt (Recent Filing)$12.03B
Price to Earnings (P/E)28.6
Beta0.23
Next Earnings
Apr 15, 2025EPS Estimate
2.65Last Dividend Ex-Date
Feb 18, 2025Dividend Yield2.99%
Share Statistics
EPS (TTM)5.80
Shares Outstanding2,409,847,700
10 Day Avg. Volume8,553,715
30 Day Avg. Volume9,283,964
Financial Highlights & Ratios
PEG Ratio7.75
Price to Book (P/B)N/A
Price to Sales (P/S)4.44
Price to Cash Flow (P/CF)14.10
P/FCF Ratio14.10
Enterprise Value/Market Cap0.91
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.96
Enterprise Value/Ebitda14.74
Forecast
1Y Price Target
$168.42Price Target Upside9.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
---
Bulls Say, Bears Say
Bulls Say
Business GrowthJohnson & Johnson has shown consistent business growth, evidenced by 61 consecutive years of dividend increases.
Financial PerformanceJNJ has a strong balance sheet with $25bn cash as of 4Q24, not including the announced ITCI acquisition.
Product DevelopmentAnalyst highlights a major acquisition by J&J to expand its presence in brain disease treatments, which includes access to an FDA-approved drug with significant sales potential.
Bears Say
Legal ChallengesJudge Lopez of TX Bankruptcy Court dismissed Red River's third attempt at resolving outstanding talc litigation via bankruptcy proceedings.
Patent ExpiryStelara is facing price pressure from two fronts: patent expiry and Medicare price negotiation.
Product CompetitionStelara sales are expected to decrease significantly due to the introduction of biosimilars and Medicare price discounts.
---
Ownership Overview
0.04% Insiders
18.79% Mutual Funds
14.38% Other Institutional Investors
45.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
JNJ FAQ
What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was $140.68 and its highest was $169.99 in the past 12 months.
What is Johnson & Johnson’s market cap?
Johnson & Johnson’s market cap is $399.65B.
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Apr 15, 2025 which is in 12 days.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Jan 22, 2025. The company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.992 by $0.048.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of $1.24 which represents an annual dividend yield of 2.99%. See more information on Johnson & Johnson dividends here
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate is 2.65.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,409,847,700 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of $2.04 in its last earnings report, beating expectations of $1.992. Following the earnings report the stock price went down -1.939%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Currently, no hedge funds are holding shares in JNJ
---
Johnson & Johnson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$168.42 (9.90% Upside)
$168.42 (9.90% Upside)
Blogger Sentiment
Bullish
JNJ Sentiment 92%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 603.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Bullish
Bullish news 78%
Bearish news 22%
Bearish news 22%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.24%
12-Months-Change
Fundamentals
Return on Equity
20.06%
Trailing 12-Months
Asset Growth
7.49%
Trailing 12-Months
Company Description
Johnson & Johnson
Johnson & Johnson is a multinational corporation that operates in the healthcare sector, providing a wide range of products and services across its three primary segments: Consumer Health, Pharmaceutical, and Medical Devices. The company's Consumer Health division offers well-known brands in baby care, skin and hair care, wound care, and over-the-counter pharmaceutical products. Its Pharmaceutical segment focuses on manufacturing and marketing a broad portfolio of medications, targeting areas such as immunology, oncology, neurology, and infectious diseases. The Medical Devices segment provides products used in orthopedic, surgery, vision, and cardiovascular fields. Established in 1886, Johnson & Johnson is headquartered in New Brunswick, New Jersey, and is recognized globally for its commitment to improving health and well-being.
---
JNJ Company Deck
---
JNJ Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Johnson & Johnson showed robust growth in sales and innovation in 2024, particularly in the Innovative Medicine and MedTech sectors. However, earnings were negatively impacted by STELARA biosimilars and recent acquisitions, while challenges in China and decreased margins were noted.Read More>---
JNJ Sales Breakdown
64.13% Innovative Medicine
35.87% MedTech
---
JNJ Stock 12 Month Forecast
Average Price Target
$168.42
▲(9.90% Upside)
Technical Analysis
Best Analysts Covering JNJ
1 Year
1 Year Success Rate
23/23 ratings generated profit
1 Year Average Return
+9.82%
reiterated a buy rating 2 days ago
Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.82% per trade.
---